ClinicalTrials.gg
Drug

Remifentanil clinical trials

Also written Ultiva and remifentanyl.

studies test it
280
open now
18
in phase 3
19
first study started
2003

How each study uses Remifentanil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Remifentanil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Jul 1996 · ULTIVA · NDA 020630 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Remifentanil
203
Remifentanil infusion
11
Remifentanil Hydrochloride
7
Remifentanil group
5
Remifentanil Hydrochloride for Injection
5

Brand

Ultiva
69

Other names

remifentanyl
6

In one entry with another drug

Given together, or one or the other

propofol and remifentanil
5
Sevoflurane and Remifentanil
3
remifentanil and propofol
2
Remifentanil and Desflurane
2
propofol, remifentanil
2

Studies by the year they started

279 studies that test it; most in 2015 (22)

Studies that test Remifentanil, by start year
YearStudies
20032
20046
20056
20067
20077
200814
200912
201018
201117
201219
201317
201420
201522
201616
201713
20188
201913
20207
202110
20227
202314
202410
20255
20269

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
11
Phase 2
15
Phase 3
19
Phase 4
122
No phase
116

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 273

Yonsei University (8) · Seoul National University Hospital (7) · Ajou University School of Medicine (6) · Yeungnam University College of Medicine (5) · Severance Hospital (5) · Changhai Hospital (5) · Medical University of Vienna (5) · Inonu University (4)

Often tested with

Tested in the same studies.

Propofol (49) · Dexmedetomidine (45) · Sevoflurane (20) · Fentanyl (16) · Ketamine (10) · Midazolam (10) · Desflurane (9) · Sufentanil (9)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Remifentanil is the comparator. A study of two new drugs counts under both.

  • 1Fentanyl · KK Women's and Children's Hospital
  • 1Ropivacaine · KK Women's and Children's Hospital
Reaching primary completion within a year · 6, 1 in phase 3

Studies that test Remifentanil, phase 3 first.

Studies

Open first, then newest update. How each study uses Remifentanil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 280

See all 280 studies that test Remifentanil →

Given beside what is tested · 66 — Remifentanil is usual care or a partner of the new treatment

Showing 20 of 66.

As the comparator · 50 — what is tested is compared with Remifentanil

Showing 20 of 50.

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Remifentanil · ClinicalTrials.gg INT006663

  • MeSH (NLM) D000077208RemifentanilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) P10582JYYKREMIFENTANILConfirmed FDA, NLM, Wikidata
  • RxNorm 73032Confirmed FDA, Wikidata
  • Wikidata Q417902remifentanilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66513RemifentanilOne source FDA
  • DrugBank DB00899One source Wikidata

Also registered as remifentanil hydrochloride (UNII 5V444H5WIC · RxNorm 236540).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.